Sigma Pharmaceuticals: Chairman's Address to Shareholders
Sigma Pharmaceuticals: Chairman's Address to Shareholders
About this item
Full title
Publisher
Melbourne: News Bites Pty Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Melbourne: News Bites Pty Ltd
Subjects
More information
Scope and Contents
Contents
An increase in revenue of 10.2% to $3.5 billion; Underlying Net Profit After Tax of $59.2 million, an increase of 11.6%; We maintained our high dividend payout ratio, paying 91% of NPAT as a dividend An increased final ordinary dividend to 3.0 cents per share fully franked, rewarding shareholders for the improved performance and signaling our confi...
Alternative Titles
Full title
Sigma Pharmaceuticals: Chairman's Address to Shareholders
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_wirefeeds_1786316178
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1786316178